Olipop, a leading prebiotic soda brand, has successfully raised $50 million in its latest funding round, achieving a valuation of $1.85 billion amid significant consumer interest in health-focused beverages.
Target Information
Olipop, a prebiotic soda brand founded in 2018, has emerged as a leading player in the rapidly expanding prebiotic beverage market. Recently valued at $1.85 billion following a $50 million funding round, the company has gained traction among consumers for its health-focused claims, particularly regarding gut health. The brand's innovative approach combines traditional soda flavors with functional health benefits, appealing to a diverse consumer base.
Since its inception, Olipop has made significant strides in the beverage industry, contributing to the growth of the nonalcoholic market segment. It has managed to capture a large share of soda drinkers seeking healthier alternatives, with notable success among younger demographics such as Gen Z, where about one in four consumers reports drinking Olipop regularly.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The beverage industry in the United States has seen a remarkable shift toward healthier options, with prebiotic sodas gaining popularity alongside other functional beverages. In recent years, health-conscious consumer trends have been at the forefront, driving brands like O
Similar Deals
Eshbal Functional Food Inc. → Dare to be Different Foods, Inc.
2025
Constellation Brands, Inc. → The Wine Group
2025
Essity → Edgewell Personal Care’s feminine care business
2025
J.P. Morgan Private Capital's Growth Equity Partners
invested in
Olipop
in 2023
in a Other deal
Disclosed details
Transaction Size: $50M
Revenue: $400M
Enterprise Value: $1,850M
Equity Value: $1,850M
Multiples
EV/Revenue: 4.6x
P/Revenue: 4.6x